5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.39▼ | 7.35▼ | 7.33▼ | 7.60▼ | 7.60▼ |
MA10 | 7.39▼ | 7.33▼ | 7.36▼ | 7.44▼ | 7.70▼ |
MA20 | 7.38▼ | 7.38▼ | 7.46▼ | 7.59▼ | 7.52▼ |
MA50 | 7.33▼ | 7.54▼ | 7.59▼ | 7.77▼ | 5.75▲ |
MA100 | 7.36▼ | 7.55▼ | 7.54▼ | 7.42▼ | 5.30▲ |
MA200 | 7.45▼ | 7.58▼ | 7.73▼ | 6.12▲ | 10.56▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | 0.012▲ | -0.012▼ | -0.007▼ | -0.138▼ |
RSI | 42.426▼ | 43.481▼ | 40.225▼ | 45.877▼ | 52.967▲ |
STOCH | 62.614 | 47.424 | 31.440 | 64.477 | 49.244 |
WILL %R | -100.000▼ | -60.000 | -72.340 | -61.501 | -59.891 |
CCI | -177.572▼ | 39.080 | -36.920 | -54.620 | -62.182 |
Thursday, May 01, 2025 06:47 PM
Q1 2025 earnings reveal Adaptive Biotechnologies' 34% MRD revenue growth, improved margins, and raised guidance.
|
Thursday, May 01, 2025 01:05 PM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...
|
Wednesday, April 30, 2025 02:20 PM
Adaptive Biotechnologies (NASDAQ:ADPT) is scheduled to announce Q1 earnings results on Thursday, May 1st, after market close. The consensus EPS Estimate is -$0.31 and the consensus Revenue Estimate is ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 7.44 | 7.51 | 7.20 | 7.36 | 2,016,780 |
30/04/25 | 7.41 | 7.67 | 7.16 | 7.36 | 1,990,973 |
29/04/25 | 7.73 | 7.77 | 7.46 | 7.60 | 1,458,792 |
28/04/25 | 7.92 | 8.05 | 7.71 | 7.77 | 1,138,470 |
25/04/25 | 7.80 | 7.96 | 7.68 | 7.90 | 868,155 |
24/04/25 | 7.36 | 8.03 | 7.255 | 7.89 | 2,358,308 |
23/04/25 | 7.42 | 7.86 | 7.33 | 7.38 | 1,886,370 |
22/04/25 | 6.90 | 7.19 | 6.90 | 7.01 | 2,618,330 |
21/04/25 | 7.17 | 7.39 | 6.7747 | 6.83 | 2,309,545 |
17/04/25 | 7.41 | 7.55 | 7.25 | 7.33 | 1,270,322 |
|
|
||||
|
|
||||
|
|